Prescription Drugs Being Sold Abroad Amidst Shortage

.

Prescription Drugs Being Sold Abroad Amidst Shortage

A shortage of prescription drugs has been witnessed by patients at the NHS. However, it has been recently revealed that the patients’ health is being jeopardized as the medication is being sold abroad rather than making them available for the patients.

The financial crisis has no doubt put many countries in a tight position. But it doesn’t mean that the government can play with the lives of the public by selling off life saving drugs to other countries at higher revenue.

It has come to light that making the drugs available for sale in the UK market abroad has caused an extreme shortage of drugs in the UK. A survey has highlighted that about half of the patients suffer because of the lack of the availability of drugs.

The survey was conducted by Chemist and Druggist magazine. For the survey, as many as 322 pharmacists were questioned. Out of them about 85% said that the health of the patients is being out at the risk by the practice of selling the drugs abroad.

There have been numerous incidences when patients had been made to wait to get medications. Half of the patients have either have faced severe illness or have succumbed to death. Not only the manufacturers are selling drugs abroad, the NHS has also been accused of following the footsteps.

While commenting upon the shortage of medicines in the market, a teaching and education consultant said, “It puts a huge amount of stress on you …I don't want to get a recurrence of my cancer - but if you miss out on your drugs, that leaves an opening for it to come back”.

The Department of Health has clearly stated that it can’t do anything to stop the trade. Therefore, the government should step in stooping the sales of drugs on the cost of patient’s health.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves